Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics

類似資料

• Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003
  著者:: Lennard, Lynne, 等
  出版事項: (2015)
• Thiopurine methyltransferase genotype–phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia
  著者:: Lennard, Lynne, 等
  出版事項: (2013)
• Meta-analysis of randomized trials comparing thiopurines in childhood acute lymphoblastic leukaemia
  著者:: Escherich, Gabriele M, 等
  出版事項: (2011)
• Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity
  著者:: Lennard, L., 等
  出版事項: (1997)
• Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.
  著者:: Lennard, L, 等
  出版事項: (1993)